ArticleiScience2026
Mechanistic evidence for dibutyl phthalate as an environmental trigger for inflammatory bowel disease.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dibutyl phthalate (DBP) is a ubiquitous pollutant, but its molecular link to inflammatory bowel disease (IBD) is undefined. We employed an integrative network toxicology framework, combining DBP target databases with IBD patient transcriptomics to address this gap. A computational pipeline using machine learning and molecular docking predicted a core six-gene signature (KYNU, PCK1, LCN2, CDC25B, EPHB4, SORD). We validated these predictions in human colonic epithelial cells (NCM460). DBP exposure induced a pro-inflammatory state and upregulated the core genes, with LCN2 showing the strongest response. Crucially, siRNA-mediated silencing of LCN2 significantly attenuated the DBP-induced inflammatory response, establishing it as a key functional mediator. Our findings provide direct mechanistic insight into how DBP can promote intestinal inflammation. The functional validation of LCN2 confirms the predictive power of our integrated approach and identifies a panel of target genes for future IBD investigation and environmental risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.